Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for an estimated 60-80% of cases worldwide. Presently, there is no effective treatment for AD and only very limited medicines show the potential for delaying the progression of this neurodegenerative disease at its early stage. On the other hand, amnestic mild cognitive impairment